Search Results

There are 432660 results for: content related to: Prostate-specific antigen response after short-term hormone therapy plus external-beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413

  1. You have free access to this content
    Impact of biochemical failure classification on clinical outcome: A secondary analysis of Radiation Therapy Oncology Group 9202 and 9413

    Cancer

    Volume 121, Issue 6, March 15, 2015, Pages: 844–852, Daniel A. Hamstra, Kyounghwa Bae, Gerald Hanks, Chen Hu, William U. Shipley, Charlie C. Pan, Mack Roach III, Colleen A. Lawton and Howard M. Sandler

    Version of Record online : 19 NOV 2014, DOI: 10.1002/cncr.29146

  2. You have free access to this content
    Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors

    Cancer

    Volume 120, Issue 12, 15 June 2014, Pages: 1800–1809, Anthony E. Rizzardi, Rachel Isaksson Vogel, Joseph S. Koopmeiners, Colleen L. Forster, Lauren O. Marston, Nikolaus K. Rosener, Natalia Akentieva, Matthew A. Price, Gregory J. Metzger, Christopher A. Warlick, Jonathan C. Henriksen, Eva A. Turley, James B. McCarthy and Stephen C. Schmechel

    Version of Record online : 25 MAR 2014, DOI: 10.1002/cncr.28646

  3. You have free access to this content
    Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database

    Cancer

    Volume 122, Issue 2, January 15, 2016, Pages: 222–229, Brian T. Hanyok, Lauren E. Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Edwin M. Posadas and Stephen J. Freedland

    Version of Record online : 20 OCT 2015, DOI: 10.1002/cncr.29748

  4. PMH 9907: Long-term outcomes of a randomized phase 3 study of short-term bicalutamide hormone therapy and dose-escalated external-beam radiation therapy for localized prostate cancer

    Cancer

    Volume 122, Issue 16, August 15, 2016, Pages: 2595–2603, Andrew J. McPartlin, Rachel Glicksman, Melania Pintilie, Debbie Tsuji, Gary Mok, Andrew Bayley, Peter Chung, Robert G. Bristow, Mary K. Gospodarowicz, Charles N. Catton, Michael Milosevic and Padraig R. Warde

    Version of Record online : 24 MAY 2016, DOI: 10.1002/cncr.30093

  5. Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors

    Cancer

    Vivek Verma, Valerie K. Shostrom, Sameera S. Kumar, Weining Zhen, Christopher L. Hallemeier, Steve E. Braunstein, John Holland, Matthew M. Harkenrider, Adrian S. Iskhanian, Hanmanth J. Neboori, Salma K. Jabbour, Albert Attia, Percy Lee, Fiori Alite, Joshua M. Walker, John M. Stahl, Kyle Wang, Brian S. Bingham, Christina Hadzitheodorou, Roy H. Decker, Ronald C. McGarry and Charles B. Simone II

    Version of Record online : 14 OCT 2016, DOI: 10.1002/cncr.30375

  6. Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

    Cancer

    Volume 122, Issue 19, October 1, 2016, Pages: 3005–3014, Abhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, Hai-Lin Wang, Mahmoud Aljurf, Joseph Harry Antin, Minoo Battiwalla, Martin Bornhauser, Jean-Yves Cahn, Bruce Camitta, Yi-Bin Chen, Corey S. Cutler, Robert Peter Gale, Siddhartha Ganguly, Mehdi Hamadani, Yoshihiro Inamoto, Madan Jagasia, Rammurti Kamble, John Koreth, Hillard M. Lazarus, Jane Liesveld, Mark R. Litzow, David I. Marks, Taiga Nishihori, Richard F. Olsson, Ran Reshef, Jacob M. Rowe, Ayman A. Saad, Mitchell Sabloff, Harry C. Schouten, Thomas C. Shea, Robert J. Soiffer, Geoffrey L. Uy, Edmond K. Waller, Peter H. Wiernik, Baldeep Wirk, Ann E. Woolfrey, Donald Bunjes, Steven Devine, Marcos de Lima, Brenda M. Sandmaier, Dan Weisdorf, Hanna Jean Khoury and Wael Saber

    Version of Record online : 17 JUN 2016, DOI: 10.1002/cncr.30140

  7. Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study

    Cancer

    Abigail D. Winder, Kruti P. Maniar, Jian-Jun Wei, Dachao Liu, Denise M. Scholtens, John R. Lurain, Julian C. Schink, Barbara M. Buttin, Virginia L. Filiaci, Heather A. Lankes, Nilsa C. Ramirez, Kay Park, Meenakshi Singh, Richard W. Lieberman, Robert S. Mannel, Matthew A. Powell, Floor J. Backes, Cara A. Mathews, Michael L. Pearl, Angeles Alvarez Secord, David J. Peace, David G. Mutch, William T. Creasman and J. Julie Kim

    Version of Record online : 7 DEC 2016, DOI: 10.1002/cncr.30477

  8. You have free access to this content
    The association between C-reactive protein (CRP) level and biochemical failure-free survival in patients after radiation therapy for nonmetastatic adenocarcinoma of the prostate

    Cancer

    Volume 119, Issue 18, 15 September 2013, Pages: 3272–3279, William A. Hall, Dana C. Nickleach, Viraj A. Master, Roshan S. Prabhu, Peter J. Rossi, Karen Godette, Sherri Cooper and Ashesh B. Jani

    Version of Record online : 1 JUL 2013, DOI: 10.1002/cncr.28185

  9. You have free access to this content
    Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer

    Cancer

    Volume 122, Issue 9, May 1, 2016, Pages: 1312–1337, A. Blythe Ryerson, Christie R. Eheman, Sean F. Altekruse, John W. Ward, Ahmedin Jemal, Recinda L. Sherman, S. Jane Henley, Deborah Holtzman, Andrew Lake, Anne-Michelle Noone, Robert N. Anderson, Jiemin Ma, Kathleen N. Ly, Kathleen A. Cronin, Lynne Penberthy and Betsy A. Kohler

    Version of Record online : 9 MAR 2016, DOI: 10.1002/cncr.29936

  10. You have free access to this content
    The impact of pathologic staging on the long-term oncologic outcomes of patients with clinically high-risk prostate cancer

    Cancer

    Volume 120, Issue 11, 1 June 2014, Pages: 1656–1662, Michael R. Abern, Martha K. Terris, William J. Aronson, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg and Stephen J. Freedland

    Version of Record online : 19 MAR 2014, DOI: 10.1002/cncr.28647

  11. You have free access to this content
    Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi-institutional retrospective study

    Cancer

    Volume 121, Issue 3, February 1, 2015, Pages: 423–431, Jorge J. Castillo, Mark Bower, Jérémy Brühlmann, Urban Novak, Hansjakob Furrer, Paula Y. Tanaka, Caroline Besson, Silvia Montoto, Kate Cwynarski, Jeremy S. Abramson, Samir Dalia, Michele Bibas, Joseph M. Connors, Michael Furman, Minh-Ly Nguyen, Timothy P. Cooley, Brady E. Beltran, Jaime A. Collins, Julie M. Vose, Blanca Xicoy, Josep-Maria Ribera and for the HIV-Associated Hodgkin Lymphoma in the cART Era Study Group

    Version of Record online : 23 SEP 2014, DOI: 10.1002/cncr.29066

  12. Caring for caregivers and patients: Research and clinical priorities for informal cancer caregiving

    Cancer

    Volume 122, Issue 13, July 1, 2016, Pages: 1987–1995, Erin E. Kent, Julia H. Rowland, Laurel Northouse, Kristin Litzelman, Wen-Ying Sylvia Chou, Nonniekaye Shelburne, Catherine Timura, Ann O'Mara and Karen Huss

    Version of Record online : 17 MAR 2016, DOI: 10.1002/cncr.29939

  13. SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma

    Cancer

    Volume 122, Issue 6, March 15, 2016, Pages: 868–874, Scott M. Schuetze, J. Kyle Wathen, David R. Lucas, Edwin Choy, Brian L. Samuels, Arthur P. Staddon, Kristen N. Ganjoo, Margaret von Mehren, Warren A. Chow, David M. Loeb, Hussein A. Tawbi, Daniel A. Rushing, Shreyaskumar R. Patel, Dafydd G. Thomas, Rashmi Chugh, Denise K. Reinke and Laurence H. Baker

    Version of Record online : 28 DEC 2015, DOI: 10.1002/cncr.29858

  14. You have free access to this content
    Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer

    Cancer

    Volume 120, Issue 11, 1 June 2014, Pages: 1620–1629, Mack Roach III

    Version of Record online : 3 MAR 2014, DOI: 10.1002/cncr.28594

  15. You have full text access to this OnlineOpen article
    Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer

    Cancer

    Volume 120, Issue 7, 1 April 2014, Pages: 1076–1082, Bradford S. Hoppe, Jeff M. Michalski, Nancy P. Mendenhall, Christopher G. Morris, Randal H. Henderson, Romaine C. Nichols, William M. Mendenhall, Christopher R. Williams, Meredith M. Regan, Jonathan J. Chipman, Catrina M. Crociani, Howard M. Sandler, Martin G. Sanda and Daniel A. Hamstra

    Version of Record online : 30 DEC 2013, DOI: 10.1002/cncr.28536

  16. You have free access to this content
    Impact of obesity on outcomes after definitive dose-escalated intensity-modulated radiotherapy for localized prostate cancer

    Cancer

    Volume 121, Issue 17, September 1, 2015, Pages: 3010–3017, Lora S. Wang, Colin T. Murphy, Karen Ruth, Nicholas G. Zaorsky, Marc C. Smaldone, Mark L. Sobczak, Alexander Kutikov, Rosalia Viterbo and Eric M. Horwitz

    Version of Record online : 29 MAY 2015, DOI: 10.1002/cncr.29472

  17. You have free access to this content
    Defining the optimal approach to the patient with postradiation prostate-specific antigen recurrence using outcome data from a prospective randomized trial

    Cancer

    Volume 119, Issue 18, 15 September 2013, Pages: 3280–3286, Miranda B. Kim, Ming-Hui Chen, Mário de Castro, Marian Loffredo, Philip W. Kantoff and Anthony V. D'Amico

    Version of Record online : 24 JUN 2013, DOI: 10.1002/cncr.28202

  18. You have free access to this content
    Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial

    Cancer

    Volume 121, Issue 14, July 15 2015, Pages: 2422–2430, Deborah W. Bruner, Daniel Hunt, Jeff M. Michalski, Walter R. Bosch, James M. Galvin, Mahul Amin, Canhua Xiao, Jean-Paul Bahary, Malti Patel, Susan Chafe, George Rodrigues, Harold Lau, Marie Duclos, Madhava Baikadi, Snehal Deshmukh and Howard M. Sandler

    Version of Record online : 2 APR 2015, DOI: 10.1002/cncr.29362

  19. You have free access to this content
    Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: Results from the REDUCE study

    Cancer

    Volume 120, Issue 2, 15 January 2014, Pages: 190–196, Daniel M. Moreira, J. Curtis Nickel, Leah Gerber, Roberto L. Muller, Gerald L. Andriole, Ramiro Castro-Santamaria and Stephen J. Freedland

    Version of Record online : 9 DEC 2013, DOI: 10.1002/cncr.28349

  20. You have free access to this content
    Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

    Cancer

    Volume 121, Issue 20, October 15, 2015, Pages: 3709–3716, Jennifer E. Vaughn, Mohamed L. Sorror, Barry E. Storer, Thomas R. Chauncey, Michael A. Pulsipher, Richard T. Maziarz, Michael B. Maris, Parameswaran Hari, Ginna G. Laport, Georg N. Franke, Edward D. Agura, Amelia A. Langston, Andrew R. Rezvani, Rainer Storb, Brenda M. Sandmaier and David G. Maloney

    Version of Record online : 24 JUL 2015, DOI: 10.1002/cncr.29498